BioNTech Covid-19 Vaccine manufacturing facility in Germany MARBURG, GERMANY - MARCH 29: Employees in special suits test the procedures for the manufacturing of the messenger RNA (mRNA) for the Covid-19 vaccine in German company BioNTech, in Marburg, Germany on March 29, 2021. BioNTech Marburg s coronavirus vaccine production target will be 2.5 billion doses for 2021, up from 2.3 billion as it is considered as one of the largest manufacturing facilities producing mRNA vaccines in the world. The Pfizer-BioNTech vaccine was developed by Ozlem Tureci and Ugur Sahin, a couple who are children of Turkish immigrants in Germany. Berlin Germany. Editorial use only. Please get in touch for any other usage.
Choose your license
Rights Managed:
One-time editorial use in an online article, social media channels, internal presentation, website, newsletter, or blog.
One-time editorial use in a book, newspaper or magazine (excluding cover page), external presentation. Limited to 5,000 circulation. This includes the rights available in the Standard license.
Media Info
Credit: Anadolu Agency
Media ID:
Recording Date: Mar 31, 2021
Media Size: 5,115×3,434 Pixels
BioNTech Covid-19 Vaccine manufacturing facility in Germany MARBURG, GERMANY - MARCH 29: Employees in special suits test the procedures for the manufacturing of the messenger RNA (mRNA) for the Covid-19 vaccine in German company BioNTech, in Marburg, Germany on March 29, 2021. BioNTech Marburg s coronavirus vaccine production target will be 2.5 billion doses for 2021, up from 2.3 billion as it is considered as one of the largest manufacturing facilities producing mRNA vaccines in the world. The Pfizer-BioNTech vaccine was developed by Ozlem Tureci and Ugur Sahin, a couple who are children of Turkish immigrants in Germany. Berlin Germany. Editorial use only. Please get in touch for any other usage.
Restrictions: This image can not be published in Turkey, United States, Canada, United Kingdom, Japan, Italy, France, Australia, Spain, Belgium, Republic of Korea, South Africa, Hong Kong and New Zealand.
Release Info: Do I need a release?
Captions may have been translated or enriched by an AI system.
For more information about AI-assisted captions, see AI-assisted captions.
Need a custom license?
If your intended use isn't covered by the available options (such as non-editorial purposes or specific distribution needs), contact us. Our team will be happy to provide a tailored offer based on your requirements.
Request an Offer